infectagentscancer.biomedcentral.comHome page | Infectious Agents and Cancer

Advertisement Search Explore journals Get published About BMC My account Search all BMC articles Search Infectious Agents and Cancer Home About Articles Submission Guidelines Search Submit manuscript Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect Women with HSIL typically undergo conization/LEEP to remove cervical lesions, but the risk of HSIL lesions returning after surgical treatment remains higher than in the general population. HPV vaccination is essential to prevent cervical cancer. However, the effect of prophylactic HPV vaccination on reducing the risk of recurrent cervical lesions after surgical treatment remains unclear. This review aims to analyze and summarize the latest literature on the role of prophylactic HPV vaccine in reducing the recurrence of cervical lesions after surgery in patients with HSIL, and to review and update the history, efficacy, effectiveness and safety of HPV vaccine, focusing on the current status of global HPV vaccine implementation and obstacles. In this article there is increasing evidence that HPV vaccination reduces the risk of recurrent cervical lesions in women with surgically treated HSIL. Infectious Agents and Cancer is commissioning for a collection on COVID-19 in Cancer . Please click the links for more information about the collection, and to discover published content. Please click here to submit your manuscript. IARC Evidence Summary Brief No. 4 IARC (2023). Protection from a Single Dose of HPV Vaccine: A major public health impact from IARC studies of vaccine efficacy (IARC Evidence Summary Briefs, No. 4). Lyon, France: International Agency for Research on Cancer. Available from: https://www.iarc.who.int/evidence-summarybriefs-series/. Aims and scope Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer. The journal welcomes submissions in the pathogen-related cancer areas and other related topics pertinent to the development of therapies for chronic infections and cancer. Of particular interest are HPV and anogenital cancers (as well as head and neck cancers), EBV and Burkitt lymphoma, HCV/HBV and hepatocellular carcinoma (as well as lymphoproliferative diseases), HHV8 and Kaposi sarcoma, HTLV and leukemia and Cancers in Low- and Middle-income countries. Please click here for more information. Articles Recent Most accessed Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation Authors: Arash Letafati, Atefeh Bahavar, Alijan Tabarraei, Mehdi Norouzi, Abdollah Amiri and Sayed-Hamidreza Mozhgani Content type: Research 11 May 2024 The performance of single and combination test strategies using visual inspection, cytology, high-risk HPV DNA and HPV16/18 to screen South African women with and without HIV-infection Authors: Greta Dreyer, Cathy Visser, Gerrit Jan Dreyer, Matthys H. Botha, Frederick H. van der Merwe, Karin L. Richter and Leon C. Snyman Content type: Research 9 May 2024 Prevalence of metabolic syndrome among patients with hepatocellular carcinoma of different etiologies: a retrospective study Authors: Da-Long Yang, Shao-Ping Liu, Hong-Liang Wang, Jian-Rong Li, Jia-Yong Su, Min-Jun Li, Yu-Xian Teng, Zhu-Jian Deng, Zhong-Hai Li, Jian-Li Huang, Ping-Ping Guo, Liang Ma, Zhen-Zhen Li and Jian-Hong Zhong Content type: Research 1 May 2024 Expression of 10 circulating cytokines/chemokines in HBV-related liver disease Authors: Yanfang Jia, Xiaolei Jiao, Wenxia Shi, Ying Luo, Huiling Xiang, Jing Liang and Yingtang Gao Content type: Research 1 May 2024 Hepatitis B virus reactivation in hepatocellular carcinoma patients after hepatic arterial infusion chemotherapy combined with and without immunotherapy Authors: Lijie Zhang, Yiming Liu, Songlin Song, Joyman Makamure, Heshui Shi, Chuansheng Zheng and Bin Liang Content type: Research 30 April 2024 Most recent articles RSS View all articles Simian virus 40 in humans Authors: Fernanda Martini, Alfredo Corallini, Veronica Balatti, Silvia Sabbioni, Cecilia Pancaldi and Mauro Tognon Content type: Review 9 July 2007 HPV E6/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review Authors: Awoke Derbie, Daniel Mekonnen, Yimtubezinash Woldeamanuel, Xaveer Van Ostade and Tamrat Abebe Content type: Review 7 February 2020 HPV vaccines and cancer prevention, science versus activism Authors: Lucija Tomljenovic, Judy Wilyman, Eva Vanamee, Toni Bark and Christopher A Shaw Content type: Letter to the Editor 1 February 2013 Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline Authors: Mark Schiffman, Gary Clifford and Franco M Buonaguro Content type: Review 1 June 2009 Bacteria and tumours: causative agents or opportunistic inhabitants? Authors: Joanne Cummins and Mark Tangney Content type: Review 28 March 2013 Most accessed articles RSS View all articles Springer Nature Oncology Portfolio Discover the range of academic oncology titles at Springer Nature here . Colorectal Cancer Awareness Month In recognition of Colorectal Cancer Awareness Month this March, we have selected a collection of articles on colorectal cancer from across our open access portfolio. Together, these articles contribute to the evolving landscape of colorectal cancer research and the fight against this prevalent and impactful disease. Article-processing charge discount for AORTIC members Infectious Agents and Cancer are proudly affiliated with the African Organization for Research and Training in Cancer (AORTIC). All members of AORTIC receive a 15% discount on the article-processing charge for each article accepted for publication. This discount can be requested during the submission process and will be verified before being applied. Standard waiver rules apply for low-income countries. AORTIC position statement The African Organization for Research and Training in Cancer (AORTIC) has published a critical appraisal of the state on cancer research and cancer care in Africa including information on the availability of data on cancer burden, screening and prevention for cancer in Africa, cancer care personnel, treatment modalities, and access to cancer care. Please click here to read the position statement. From the blog A conversation on the role of mouse mammary tumour virus on human Breast Cancer with Dr Lawson and Dr Bevilacqua 25 October 2021 Africa’s cancer healthcare workforce is overworked and under-supported 21 May 2019 Editors-in-Chief Dr Franco M Buonaguro, I stituto Nazionale Tumori Fond. G. Pascale”, Naples, Italy Dr Maria Lina Tornesello, Istituto Nazionale Tumori Fond. G. Pascale”, Naples, Italy Please click here to read the Editors’ Profiles Editors’ quotes Dr Franco M. Buonaguro and Dr Maria Lina Tornesello (Co-Editors-in-Chief) and Dr Sam M Mbulaiteye (Section Editor for Cancer centers in low- and middle-income countries”) of Infectious Agents and Cancer discuss their opinion on the journal’s subject field. Cancers related to infectious diseases represent a very significant component of the cancer burden in humans spanning from 20% of all malignancies in industrialized countries to 40% in developing countries. Studies on pathogen-related cancers allow the identification of mechanisms relevant to oncogenesis as well as molecular markers for diagnostic/prognostic methods and targets for therapeutic strategies. Furthermore their relevance is due to the concrete possibility of preventive strategies, which are always cost-effective and can usually be implemented with relatively modest investments. The open access policy of Infectious Agents and Cancer represents a key factor to foster an even participation and contribution by Western as well as Eastern/Southern...